Sentences with phrase «share growth at»

That would put Apple's earnings - per - share growth at 10 % for the current year, compared with 80 % two years ago, and 60 % in the 2012 fiscal year that ended in September.

Not exact matches

In a statement, Lee said that the «growing «sharing economy» is leveraging technology and innovation to generate new jobs and income for San Franciscans in every neighborhood and at every income level... San Francisco must be at the forefront of nurturing its growth, modernizing our laws, and confronting emerging policy issues and concerns.»

«Overall we view the [third quarter] result as disappointing and suggestive the company continues to lose share in the majority of markets / categories, with prestige beauty brand SK - II accounting for the majority of growth,» wrote analysts at Stifel.

Make affirmations part of your culture by asking people to post it at their desk, add it to their e-mail signature, or start meetings with sharing affirmations to create an environment that supports everyone's growth.

Currently, the company is trading at about 25 times earnings and with a long - term earnings per share growth rate of about 15 %, its price - to - earnings to growth ratio — a metric used to value fast growing companies — is about 1.4.

Canopy Growth Corp. is currently valued at just over $ 7.5 billion yet loses about 12 cents a share.

Seeking to appease investors with boosts to share prices, CEOs are prioritizing short - term returns at the expense of R&D, workforce training and other investments essential to their companies» long - term growth.

Adidas shares, up 13 percent in the last three months after it announced a big share buyback in March, were down 1 percent at 0857 GMT, with traders expressing concern about the West partnership and slower growth in Europe.

Exxon's shares are way up under his leadership, but lag behind competitors, oil and gas output is down 14 % and, while making deals abroad, analysts believe he missed out on some important growth opportunities at home.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

Sanderson thinks that listening hours can expand at a 14 % compound annual growth rate through 2017 and 11 % through 2020, while its share of people who listen to music can grow from 8 % in 2013 to 18 % by 2020.

Angel investors normally provide capital for start - ups or businesses in the early stage of growth in exchange for equity, or in some cases, convertible notes, that converts into shares or cash value at a point later on.

Its surging U.S. growth appears to be coming at least partly at the expense of Blue Apron, which held twice the market share of HelloFresh in 2015 and even as recently 2016, according to data from online audience measurement firm SimilarWeb.

«Nike's brand investment, innovation levels and extensive global distribution network should allow further market share growth, often at the expensive of local competitors,» Goldman Sachs said in a recent note.

The stock's underperformance was a «headscratcher» for Jim Tierney, the chief investment officer of the $ 4 billion U.S. concentrated growth portfolio at AB (formerly AllianceBernstein), which owns Zoetis shares.

Greger Johansson, analyst at research firm Redeye who had a bull case scenario of 250 crowns per share, said he thought the main owners had been unwilling to sell below 300 crowns as Axis had high revenue growth and was the No. 1 player in its market.

Oakland - based Revolution Foods (# 2) is growing at a 5 - year compounded annual growth rate of 144 %, and is setting a new standard in the food industry by offering profit sharing to its employees.

PMI was anticipating market share growth would plateau at some point this year because the company knew it was close to saturating the early adopters and innovators, he said.

The stock is trading at the high end of its historical range, but its «industry leading earnings and free cash flow growth» make up for that higher multiple, he said The stock is currently trading at $ 191 a share, but Hansen said it will hit $ 220 over the next 12 - months.

Canada's most profitable business over the past five years, tallying $ 41.24 billion, also enjoys the best five - year share growth among Canada's Big Five Banks at 74 %.

They were looking at the growth in market share and what our top line was.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The great expectations among many U.S. residential real estate watchers is that, at some point, growth will turn away from condos and toward single - family housing, the traditional choice of America's families, which accounts for a far larger share of the market.

While Penney at least reported growth over the holidays, the results suggest lost market share, given that the overall industry outpaced it with 4 % growth, as did rivals such as Kohl's (kss) and Target (tgt).

It has some other things going for it as well: it's generating strong operating profit growth in China and Latin America; it's done a good job of extracting cost savings and it's buying back shares at a healthy clip.

Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.

But anyone hoping for the kind of stock growth Shoppers enjoyed over the past decade — when its share price climbed from less than $ 18 to, at one point, over $ 55 — will be disappointed.

At its current valuation of ~ $ 67 / share, HLF has a price to economic book value ratio (price - to - EBV) of 1.2 That ratio means that the market expects only 20 % growth in NOPAT for the remainder of HLF's existence.

These included overly optimistic economic growth and oil price assumptions; cutting the contingency reserve by two - thirds; selling shares in GM at fire sale prices; raiding EI revenues; and even booking «savings» from unilateral changes to federal employees» sick leave benefits.

Shares at that time were trading at a PEBV of 0.82, an unprecedented discount for a company with MCD's track record of growth and profitability.

At its new price of ~ $ 23 / share, the market expects 10 % compounded annual NOPAT growth for the next 11 years.

Over time this means that households will retain a growing share of China's total production of goods and services (at the expense of the elite, of course, who benefitted from subsidized borrowing costs) and so not only will they not be hurt by a sharp fall in GDP growth, but their consumption will increasingly drive growth and innovation in China.

Despite promising growth prospects in the Permian and other efforts supporting the dividend and the potential for share buybacks, a widening valuation multiple at Chevron Corporation (NYSE: CVX) is not justifiable, according to «Further Upside For Chevron Is Unjustified, BMO Analyst Says» by Shanthi Rexaline.

After taking a look at the fund's low yield and lack of consistent dividend growth, I decided to sell all the shares.

Share buybacks and cost - cutting have helped propel bottom - line growth in recent years, but this quarter sales growth is tracking at the strongest level in more than five years.

While the monthly payout is nice for individuals needing income today, I'd rather have more growth so I sold all my shares this month at a little bit of a loss and reinvested that money in my Loyal3 account.

Bad weather probably played a part, which helps explain why online sales were up over 2 % as shoppers bought at the keyboard, but tepid income growth shares a large part of the blame.

The most effective way is to chase market share and drive out one's rivals — even if doing so comes at the expense of short - term profits, since the best guarantee of long - term profits is immediate growth.

Incomes have become decoupled from economic growth because a large and rising share of economic growth has gone to households at the top of the ladder.

But if you are a high - flying growth company that is expected to grow earnings per share at 20 % every year, and you know that your stock price will plummet the first moment you post disappointing results, the incentive to engage in fraudulent behavior seems a lot greater.

«From a capital allocation perspective, we will always prioritize re-investments in our growth priorities over share buybacks,» said David Crundwell, senior vice president, corporate affairs, at Thomson Reuters.

A Reuters analysis shows that many companies are barreling down the same road, spending on share repurchases at a far faster pace than they are investing in long - term growth through research and development and other forms of capital spending.

LOS ANGELES (Reuters)- Kraft Macaroni & Cheese has been a favorite meal for generations of American children, but smaller brands made with more natural ingredients are starting to nibble at its market share, part of a trend that is biting into growth at large U.S. food companies.

Upside reward potential is strong as the stock has to go over $ 82 / share to trade at a value that implies the company's profits will experience a 0 % decline, a no - growth scenario.

But because the category grew at a faster rate than Kraft's sales growth, the company's share declined slightly, a spokesman said.

For much of the past decade there has been a growing recognition that Chinese growth has been seriously unbalanced, as Premier Wen put it, and that at the heart of the imbalance has been the very low consumption share of GDP.

Add the fact that much of the earnings - per - share growth is created by making acquisitions of slower growing, lower P / E companies, and one might think that the new, larger level of earnings should be valued at a smaller multiple than the prior earnings were.

«Investors continue to focus on revenue growth and market share gains as the primary criteria when evaluating vendors,» said John Rizzuto, research vice president and Invest analyst at Gartner.

The 18.1 % growth expected this year for US display advertising is down somewhat from more robust rates of increase in 2011 and 2012, but eMarketer continues to be bullish on the prospects for digital display advertising — especially at social media properties like Facebook and Twitter, as well as at Google, which has dramatically increased its overall share of the display market in recent years.

Join the GSAM workshop to explore EM through a multi-asset lens; looking at investment techniques for allocating across the spectrum of EM asset classes, as well as sharing our views on the most attractive opportunities for generating capital growth and income.